SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001387131-19-006938
Filing Date
2019-09-13
Accepted
2019-09-13 17:18:22
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT nbse-s3_091319.htm S-3 269575
2 OPINION OF PAUL HASTINGS LLP ex5-1.htm EX-5.1 15015
3 CONSENT OF MALONEBAILEY, LLP ex23-1.htm EX-23.1 6089
4 CONSENT OF MALONEBAILEY, LLP ex23-2.htm EX-23.2 3467
5 GRAPHIC neubase-logo.jpg GRAPHIC 67481
6 GRAPHIC ph_logo.jpg GRAPHIC 3307
7 GRAPHIC ph_footer.jpg GRAPHIC 18429
  Complete submission text file 0001387131-19-006938.txt   413179
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-233767 | Film No.: 191093231
SIC: 2834 Pharmaceutical Preparations